Terns Pharmaceuticals Inc (TERN)
5.88
+0.09
(+1.55%)
USD |
NASDAQ |
Nov 26, 16:00
5.92
+0.04
(+0.68%)
Pre-Market: 08:01
Terns Pharmaceuticals Stock Buybacks (Quarterly): -162.31M for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -162.31M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | -13.69M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -27.92M |
| December 31, 2022 | -106.11M |
| September 30, 2022 | -61.14M |
| June 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -136.36M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-162.31M
Minimum
Sep 2024
--
Maximum
Mar 2020
-26.71M
Average
--
Median
Mar 2020
Stock Buybacks (Quarterly) Benchmarks
| Eli Lilly and Co | 446.10M |
| Viking Therapeutics Inc | -46.66M |
| Biomarin Pharmaceutical Inc | -- |
| Elite Pharmaceuticals Inc | -- |
| Verrica Pharmaceuticals Inc | 0.00 |